| 47781-355 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-355 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-355 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-355 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-355 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-355 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-355 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-356 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-356 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-356 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-356 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-356 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-356 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-356 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-357 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-357 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-357 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-357 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-357 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-357 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-357 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-358 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-358 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-358 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-358 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-358 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-358 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 47781-358 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Alvogen Inc. | ANDA | Current |
| 52427-692 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Almatica Pharma Inc. | ANDA | Current |
| 52427-692 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Almatica Pharma Inc. | ANDA | Current |
| 52427-692 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Almatica Pharma Inc. | ANDA | Current |
| 52427-692 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Almatica Pharma Inc. | ANDA | Current |
| 52427-694 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Almatica Pharma Inc. | ANDA | Current |
| 52427-694 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Almatica Pharma Inc. | ANDA | Current |
| 52427-694 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Almatica Pharma Inc. | ANDA | Current |
| 52427-694 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Almatica Pharma Inc. | ANDA | Current |
| 52427-698 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Almatica Pharma Inc. | ANDA | Current |
| 52427-698 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Almatica Pharma Inc. | ANDA | Current |
| 52427-698 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Almatica Pharma Inc. | ANDA | Current |
| 52427-698 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Almatica Pharma Inc. | ANDA | Current |
| 52427-712 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Almatica Pharma Inc. | ANDA | Current |
| 52427-712 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Almatica Pharma Inc. | ANDA | Current |
| 52427-712 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Almatica Pharma Inc. | ANDA | Current |
| 52427-712 | Buprenorphine and Naloxone | Buprenorphine and Naloxone | Almatica Pharma Inc. | ANDA | Current |